Komipharm International Co. Ltd (041960) — Cash Flow-to-Debt Ratio
Komipharm International Co. Ltd (041960) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of ₩946.94 Million could theoretically repay 0% of its total liabilities (₩61.86 Billion) in one year. Explore long-term investment intensity of Komipharm International Co. Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Komipharm International Co. Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Komipharm International Co. Ltd across 13 annual periods. Also explore 041960 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Komipharm International Co. Ltd (2013–2025)
Year-by-year debt coverage analysis for Komipharm International Co. Ltd. For market capitalisation and broader financial context, see 041960 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | ₩-621.80 Million | ₩61.86 Billion | ▼ -106.5% |
| 2024 | 0.15x | ₩8.85 Billion | ₩57.23 Billion | ▲ +423.5% |
| 2023 | -0.05x | ₩-2.80 Billion | ₩58.58 Billion | ▼ -35.1% |
| 2022 | -0.04x | ₩-1.81 Billion | ₩51.12 Billion | ▼ -37.4% |
| 2021 | -0.03x | ₩-1.26 Billion | ₩48.80 Billion | ▼ -4760.6% |
| 2020 | 0.00x | ₩25.20 Million | ₩45.64 Billion | ▼ -97.0% |
| 2019 | 0.02x | ₩950.79 Million | ₩52.37 Billion | ▲ +141.9% |
| 2018 | -0.04x | ₩-2.02 Billion | ₩46.52 Billion | ▼ -983.6% |
| 2017 | 0.00x | ₩235.64 Million | ₩48.00 Billion | ▼ -77.0% |
| 2016 | 0.02x | ₩1.21 Billion | ₩56.64 Billion | ▲ +141.7% |
| 2015 | -0.05x | ₩-2.93 Billion | ₩57.26 Billion | ▼ -43.7% |
| 2014 | -0.04x | ₩-2.54 Billion | ₩71.24 Billion | ▼ -158.0% |
| 2013 | 0.06x | ₩3.93 Billion | ₩64.08 Billion | — |